Related Articles
Pathological complete response of colorectal liver metastases following chemotherapy with S-1 and oxaliplatin (SOX) in combination with bevacizumab: A case report
Role of RAS mutation status as a prognostic factor for patients with advanced colorectal cancer treated with first‑line chemotherapy based on fluoropyrimidines and oxaliplatin, with or without bevavizumab: A retrospective analysis
Preoperative chemotherapy in colorectal cancer patients with synchronous liver metastasis
Curative effect of bevacizumab combined with chemotherapy in advanced or recurrent uterine sarcoma
Bevacizumab as a last-line treatment for glioblastoma following failure of radiotherapy, temozolomide and lomustine